QA: Biomea Fusion Inc in us_pharma/2021

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001840439_2022_Biomea_Fusion_Inc.pdf

Logs

warning The stock price does not exist industry.us_generic {}
warning Ignoring company because Expenses is zero pre-agg {'balance_sheet': {'company_id': '0001840439', 'EntityCommonStockSharesOutstanding': 29396246, 'Assets': 129307000, 'AssetsCurrent': 117819000, 'ComprehensiveNetIncome': -81819000, 'CostOfGoodsAndServicesSold': 0, 'Expenses': 0, 'IntangibleAssetsNetIncludingGoodwill': 0, 'Liabilities': 20768000, 'LiabilitiesAndStockholdersEquity': 129307000, 'LiabilitiesCurrent': 19101000, 'LiabilitiesNoncurrent': 1667000, 'NetIncome': -81828000, 'PropertyPlantAndEquipmentNet': 5841000, 'ResearchAndDevelopmentExpense': 0, 'Revenues': 1806000, 'SellingGeneralAndAdministrativeExpense': 0, 'remainder_Assets': 5647000, 'remainder_ComprehensiveNetIncome': 9000, 'remainder_Expenses': 0, 'remainder_Liabilities': 0, 'remainder_LiabilitiesAndStockholdersEquity': 108539000, 'remainder_NetIncome': -83634000, 'remainder_Revenues': 1806000, 'obs_EconomicCapitalRatio': nan}}

Graph

Absolute values for 0001840439, Biomea Fusion Inc

  xvar xval
0 AssetsCurrent 176,561,000
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 2,965,000
3 remainder_Assets 6,179,000
4 LiabilitiesCurrent 4,637,000
5 LiabilitiesNoncurrent 2,285,000
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 13,671,000
9 ResearchAndDevelopmentExpense 27,996,000
10 remainder_Expenses 0
11 remainder_Revenues 0
12 remainder_NetIncome 100,000
13 remainder_ComprehensiveNetIncome -10,000
  yvar yval
0 Assets 185,705,000
1 Liabilities 6,922,000
2 Expenses 41,667,000
3 Revenues 0
4 StockholdersEquity 178,783,000
5 NetIncome -41,567,000
6 ComprehensiveNetIncome -41,572,000
7 BaseVar 117,202,000
8 EconomicCapitalRatiobeforeLimitedLiability 3.62
9 EconomicCapitalRatio 4.11

Edgar->Model Mapping

Feature Distribution